NOL Index to Compare the Intraoperative Analgesic Effect of Propofol Versus Sevoflurane

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

March 17, 2022

Study Completion Date

March 17, 2022

Conditions
Nociceptive PainAnesthesia
Interventions
DRUG

Propofol

"In the propofol group, general anesthesia will be induced using target-controlled infusion (TCI) of propofol and remifentanil. Marsh pharmacokinetic model will be used to set the initial target predicted effect-site concentration of propofol at 3.0 mcg/ml in flash mode. Simultaneously, target-controlled infusion of remifentanil will be started to reach an initial target predicted effect-site concentration of 3 ng/mL using the Minto pharmacokinetic model.~After tracheal intubation, TCI of remifentanil is paused."

DRUG

Sevoflurane

In the sevoflurane group, induction of general anesthesia will be carried out by spontaneous breathing through a mask while progressively opening up the dial of the sevoflurane vaporizer up to 8%. Like in the propofol group, target-controlled infusion of remifentanil is simultaneously started to reach an initial target predicted effect-site concentration of 3 ng/mL. Vaporizer is adjusted when gas equilibration reaches the patient-specific concentration 1.0 MAC of sevoflurane. After tracheal intubation, TCI of remifentanil is paused.

Trial Locations (1)

H1T2M4

CIUSSS de l'Est de l'Ile de Montreal, Montreal

All Listed Sponsors
lead

Ciusss de L'Est de l'Île de Montréal

OTHER

NCT04567160 - NOL Index to Compare the Intraoperative Analgesic Effect of Propofol Versus Sevoflurane | Biotech Hunter | Biotech Hunter